Wed, 21/11/2018

October 30, 2018 – Cerdanyola del Vallès (Barcelona) Spain.

The company’s product WASHDENT has qualified for the “Toothfriendly” certification after being tested at the Dental Institute of Zurich University in Switzerland and has the relevant expert’s statements affirming that it is safe for teeth. Toothfriendly International is a non-profit organisation with over 30 years' experience in testing and certifying guaranteed Toothfriendly products.

Mon, 09/07/2018

Santiago (Chile) – Cerdanyola del Vallès (Spain); July 6th, 2018.

According to this agreement, Farmoquímica del Pacífico, a family-owned pharmaceutical company with more than 150 years of history and Mitelos, a business-to-business company focused on innovation, announced that they have reached an agreement that grants the former the exclusive rights to market OTIBLOCK® in Chile.


Mon, 07/05/2018

Watford (UK) – Cerdanyola, Barcelona (Spain); May 3rd, 2018: Under this agreement, Glenmark receives exclusive rights to the United Kingdom for this product addressed to oral care.

Glenmark Pharmaceuticals, a global pharmaceutical company and Mitelos, a business to business innovation-driven company, announced that they have entered into a distribution and commercial supply agreement that grants the former the exclusive rights to market WASHDENT® in the United Kingdom.

Tue, 13/06/2017

New Mark and Mitelos agree to market the therapeutic alternative for treating impacted ear wax OTIBLOCK

Tue, 28/02/2017

WASHDENT is a food supplement, developed by Mitelos, that complements your dental hygiene routine at any time or place, when a more complete clean is not possible.

Tue, 31/01/2017

Madrid, 31 January, 2017.- Mylan and Mitelos have signed a collaboration agreement to provide Zelium to patients in Spain. Zelium is a medical device that provides therapeutic alternative to prevent the complications of diabetic foot, and that will be available soon in Spain. The diabetic foot is the result of complications of diabetes mellitus when the disease is not well controlled.

Wed, 21/09/2016

September 20, 2016.-Faes and Mitelos will make OtiFaes Taponox® available to doctors and patients.This represents a therapeutic alternative for treating impacted ear wax. OtiFaes Taponox® otic spray helps to remove impacted ear wax from the ear canal thanks to its formulation, which is oil-free and helps the ear to maintain the proper pH. OtiFaes Taponox® which is due to go on sale by Faes Farma, has been developed, registered and manufactured by Mitelos.

Thu, 03/12/2015

Palma de Mallorca and Cerdanyola del Vallès, Spain, December 1, 2015.- Sanifit and Mitelos have successfully concluded the development, registration and industrial scaled up of SNF671, a breakthrough patent protected dietary supplement to prevent osteoporosis within postmenopausal women, which was originated at the Laboratory of Renal Lithiasis Research of the University of the Balearic Islands.

Tue, 28/04/2015

Cerdanyola del Vallès (Barcelona), April 28th, 2015.- Mitelos has recently concluded a cooperation agreement with a company located in San Francisco Bay area, California, in order to offer a correspondent business development services provider with U.S. Market coverage.